This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Nanocarrier Kabushiki Kaisha, Nippon Kayaku Kabushiki Kaisha. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 801 
Years Active: 2010
Title: **Innovative Contributions of Katsuhiko Sagawa in Anticancer Treatments**
Introduction
Katsuhiko Sagawa, an accomplished inventor from Namerikawa, Japan, has made significant contributions to the field of medicinal chemistry. His work primarily focuses on developing novel drug delivery systems, particularly for anticancer agents. With a deep commitment to enhancing the efficacy and safety of treatments, Sagawa has secured a patent that underscores his innovative spirit.
Latest Patents
Sagawa holds a patent for a micellar preparation containing a sparingly water-soluble anticancer agent and a novel block copolymer. This groundbreaking invention enables heightened solubility of anticancer agents, thereby allowing for a sustained high blood concentration following intravenous administration. The formulation is designed to possess high medicinal activity while minimizing side effects, showcasing its potential for transforming the therapeutic landscape for cancer patients.
Career Highlights
Throughout his career, Katsuhiko Sagawa has worked with prominent companies, including Nippon Kayaku Kabushiki Kaisha and Nanocarrier Kabushiki Kaisha. His tenure at these organizations has provided him with a robust foundation in research and development, enabling him to advance innovative solutions in pharmaceutical technology.
Collaborations
Sagawa has collaborated with notable colleagues in the industry, such as Kazuhisa Shimizu and Toshitaka Murata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, driving forward the development of effective anticancer therapies.
Conclusion
Katsuhiko Sagawa's inventive contributions to the field of anticancer agents highlight the importance of innovation in medicine. His patent for the micellar preparation signifies a step forward in enhancing treatment efficacy while reducing adverse effects. Sagawa's career and collaborations reflect a dedication to improving patient outcomes through scientific advancement. As the landscape of cancer treatment evolves, his work will undoubtedly play a pivotal role in shaping future therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile